Associations between maternal and infant morbidities and sRAGE within the first week of life in extremely preterm infants

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Rogers, Lynette K ^a,b   Graf, Amanda E ^a,b   Bhatia, Anisha ^a   Leonhart, Karen L ^a   Oza Frank, Reena ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; PROTEIN S 100;

ARTICLE; BLOOD SAMPLING; CHORIOAMNIONITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; INFANT MORBIDITY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MATERNAL MORBIDITY; MORBIDITY; PREECLAMPSIA; PREMATURITY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SEPSIS;

ADULT; BIOLOGICAL MARKERS; COMORBIDITY; FEMALE; GESTATIONAL AGE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; MALE; PREGNANCY; PREMATURE BIRTH; S100 PROTEINS; YOUNG ADULT;

EID: 84891932309     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082537     Document Type: Article

References (33)

1. Behrman RE, Butler AS (2007) Preterm Birth, Causes, Consequences, and Prevention. Washington DC: National Academies Press.
2. Allen MC (2008) Neurodevelopmental outcomes of preterm infants. Curr Opin Neurol 21: 123-128. doi:10.1097/WCO.0b013e3282f88bb4. PubMed: 18317268. (Pubitemid 351644151)
3. Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371: 75-84. doi:10.1016/S0140-6736(08)60074-4. PubMed: 18177778.
4. Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel LA et al. (2006) Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 11: 317-326. doi:10.1016/j.siny.2006.05.001. PubMed: 16839830. (Pubitemid 44038705)
5. Viscardi RM (2012) Perinatal inflammation and lung injury. Semin Fetal Neonatal Med, 17: 30-5. PubMed: 21855435.
6. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5. PubMed: 17032697. (Pubitemid 46028489)
7. Buckley ST, Ehrhardt C (2010) The receptor for advanced glycation end products (RAGE) and the lung. J Biomed Biotechnol 2010: 917108
8. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S et al. (2006) The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 19: 1437-1445. PubMed: 16941014. (Pubitemid 44624162)
9. Schlueter C, Hauke S, Flohr AM, Rogalla P, Bullerdiek J (2003) Tissuespecific expression patterns of the RAGE receptor and its soluble forms-a result of regulated alternative splicing? Biochim Biophys Acta 1630: 1-6. doi:10.1016/j.bbaexp.2003.08.008. PubMed: 14580673. (Pubitemid 37297971)
10. Wang Y, Wang H, Piper MG, McMaken S, Mo X et al. (2010) sRAGE induces human monocyte survival and differentiation. J Immunol 185: 1822-1835. doi:10.4049/jimmunol.0903398. PubMed: 20574008.
11. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S et al. (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198: 1507-1515. doi:10.1084/jem.20030800. PubMed: 14623906. (Pubitemid 37467165)
12. Zimmer DB, Cornwall EH, Landar A, Song W (1995) The S100 protein family: history, function, and expression. Brain. Res Bull 37: 417-429.
13. Bianchi R, Kastrisianaki E, Giambanco I, Donato R (2011) S100B protein stimulates microglia migration via RAGE-dependent upregulation of chemokine expression and release. J Biol Chem 286: 7214-7226. doi:10.1074/jbc.M110.169342. PubMed: 21209080.
14. Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A et al. (2001) A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 108: E35. doi:10.1542/peds.108.2.e35. PubMed: 11483845.
15. Rogers LK, Young CM, Pennell ML, Tipple TE, Leonhart KL et al. (2012) Plasma lipid metabolites are associated with gestational age but not bronchopulmonary dysplasia. Acta Paediatr 101: e321-e326. doi: 10.1111/j.1651-2227.2012.02694.x. PubMed: 22497282.
16. Buhimschi CS, Baumbusch MA, Dulay AT, Oliver EA, Lee S et al. (2009) Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. Am J Pathol 175: 958-975. doi:10.2353/ajpath. 2009.090156. PubMed: 19679874.
17. Buhimschi IA, Zhao G, Pettker CM, Bahtiyar MO, Magloire LK et al. (2007) The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol 196: 181: e181-e113. PubMed: 17306673.
18. Thomas W, Seidenspinner S, Kawczyńska-Leda N, Wirbelauer J, Szymankiewicz M et al. (2010) Soluble receptor for advanced glycation end products (sRAGE) in tracheobronchial aspirate fluid and cord blood of very low birth weight infants with chorioamnionitis and funisitis. Early Hum Dev 86: 593-598. doi:10.1016/j.earlhumdev.2010.07.013. PubMed: 20727688.
19. Su X, Looney MR, Gupta N, Matthay MA (2009) Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury. Am J Physiol Lung Cell Mol Physiol 297: L1-L5. doi:10.1152/ajplung.90546.2008. PubMed: 19411309.
20. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT et al. (2008) Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63: 1083-1089. doi: 10.1136/thx.2008.095588. PubMed: 18566109.
21. Bopp C, Bierhaus A, Hofer S, Bouchon A, Nawroth PP et al. (2008) Bench-to-bedside review: The inflammation-perpetuating patternrecognition receptor RAGE as a therapeutic target in sepsis. Crit Care 12: 201. doi:10.1186/cc6422. PubMed: 18226173.
22. Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP et al. (2008) sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 147: 79-83. doi:10.1016/j.jss.2007.07.014. PubMed: 17981300. (Pubitemid 351626081)
23. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T et al. (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 83: 876-886. doi:10.1007/s00109-005-0688-7. PubMed: 16133426. (Pubitemid 41598688)
24. Lizotte PP, Hanford LE, Enghild JJ, Nozik-Grayck E, Giles BL et al. (2007) Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung. BMC Dev Biol 7: 15. doi:10.1186/1471-213X-7-15. PubMed: 17343756.
25. Sukkar MB, Ullah MA, Gan WJ, Wark PA, Chung KF et al. (2012) RAGE: a new frontier in chronic airways disease. Br J Pharmacol 167: 1161-1176. doi:10.1111/j.1476-5381.2012.01984.x. PubMed: 22506507.
26. Sukkar MB, Wood LG, Tooze M, Simpson JL, McDonald VM et al. (2012) Soluble RAGE is deficient in neutrophilic asthma and COPD. Eur Respir J 39: 721-729. doi:10.1183/09031936.00022011. PubMed: 21920897.
27. Reynolds PR, Schmitt RE, Kasteler SD, Sturrock A, Sanders K et al. (2010) Receptors for advanced glycation end-products targeting protect against hyperoxia-induced lung injury in mice. Am J Respir Cell Mol Biol 42: 545-551. doi:10.1165/rcmb.2008-0265OC. PubMed: 19541845.
28. Reynolds PR, Stogsdill JA, Stogsdill MP, Heimann NB (2011) Upregulation of receptors for advanced glycation end-products by alveolar epithelium influences cytodifferentiation and causes severe lung hypoplasia. Am J Respir Cell Mol Biol 45: 1195-1202. doi:10.1165/rcmb.2011-0170OC. PubMed: 21685154.
29. Stogsdill JA, Stogsdill MP, Porter JL, Hancock JM, Robinson AB et al. (2012) Embryonic overexpression of receptors for advanced glycation end-products by alveolar epithelium induces an imbalance between proliferation and apoptosis. Am J Respir Cell Mol Biol 47: 60-66. doi: 10.1165/rcmb.2011-0385OC. PubMed: 22343220.
30. Wiesmann M, Steinmeier E, Magerkurth O, Linn J, Gottmann D et al. (2010) Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP. Acta Neurol Scand 121: 178-185. doi:10.1111/j.1600-0404.2009.01196.x. PubMed: 19804476.
31. Romero R, Espinoza J, Hassan S, Gotsch F, Kusanovic JP et al. (2008) Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation. J Perinat Med 36: 388-398. PubMed: 18593373.
32. Oliver EA, Buhimschi CS, Dulay AT, Baumbusch MA, Abdel-Razeq SS et al. (2011) Activation of the receptor for advanced glycation end products system in women with severe preeclampsia. J Clin Endocrinol Metab 96: 689-698. doi:10.1210/jc.2010-1418. PubMed: 21325454.
33. Kwon JH, Kim YH, Kwon JY, Park YW (2011) Clinical significance of serum sRAGE and esRAGE in women with normal pregnancy and preeclampsia. J Perinat Med 39: 507-513. PubMed: 21767223.